Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)

15 filings reported holding ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock as of Q2 2024.
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 7.31M shares of 41.1M outstanding shares and own 17.8% of the company stock.
Largest 10 shareholders include 22NW, LP (5.37M shares), LVW Advisors, LLC (642K shares), Nantahala Capital Management, LLC (511K shares), MORGAN STANLEY (399K shares), Ikarian Capital, LLC (158K shares), VANGUARD GROUP INC (154K shares), GEODE CAPITAL MANAGEMENT, LLC (51.3K shares), BOOTHBAY FUND MANAGEMENT, LLC (19K shares), BlackRock Inc. (3.76K shares), and Tower Research Capital LLC (TRC) (3.3K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.